Weber-cockayne Syndrome
📧 Sign up to get email alerts when something new happens for Weber-cockayne Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study [Phase 2]
Phase 2 trial investigating topical sirolimus 2% for Epidermolysis Bullosa Simplex and related conditions has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study [Phase 2]
Phase 2 clinical trial update evaluating topical sirolimus 2% for patients with epidermolysis bullosa simplex.